Shrestha Prezma, Kuikel Sandip, Bajracharya Sunita, Ghimire Anup, Shrestha Roshan, Mishra Aman, Bhandari Puja, Bhattarai Shiva Lal, Nepal Amit Sharma
Department of Obstetrics and Gynaecology, Tribhuvan University Institute of Medicine, Kathmandu, Nepal.
Maharajgunj Medical Campus, Tribhuvan University Institute of Medicine, Kathmandu, Nepal.
Ann Med Surg (Lond). 2022 Aug 1;80:104293. doi: 10.1016/j.amsu.2022.104293. eCollection 2022 Aug.
The prevalence and paradigm of antenatal heart disease are contrasting between high-income, industrialized, and low- and middle-income countries. In this systematic review, we report the prevalence of heart disease and its spectrum in pregnant women of South Asia.
We searched through different electronic databases (PubMed, Google-scholar, Embase, Cochrane Library) to locate relevant articles. Studies with sufficient data that met our inclusion criteria were included. Two reviewers independently screened the articles. Discrepancies were resolved by other reviewers. Subsequently, data extraction was done using a standardized form and quality assessment of studies using the Joanna Briggs Institute tool. Meta-analysis was done using R software.
After various stages of screening 25 studies were included in the final quantitative synthesis. The pooled prevalence of heart disease among pregnant women was 1.46% (95% CI 0.99-2.01). Among those with heart disease, 70.25% (95% CI 64.87-75.38) had Rheumatic heart disease and 18.10% (95% CI 14.39-22.12) had congenital heart disease. The pooled prevalence of preterm labor and delivery among pregnant women with heart disease was 17.63% (95% CI 12.18-23.80). Similarly, the pooled maternal and fetal mortality rates were 26.14 (95% CI 12.47-43.55) and 50.48 (95% CI 29.59-75.83) per 1000 pregnant women with heart disease respectively.
As pregnancy, itself is a prolonged state of physiologic stress, heart disease further adds to the risk both for the mother and fetus. Having such a high prevalence, efforts must be made to detect and closely monitor the condition antenatally, and decisions should be made according to the clinical conditions of the patient.
高收入工业化国家与低收入和中等收入国家的产前心脏病患病率及模式存在差异。在本系统评价中,我们报告了南亚孕妇心脏病的患病率及其谱系。
我们通过不同的电子数据库(PubMed、谷歌学术、Embase、考克兰图书馆)检索相关文章。纳入具有足够数据且符合我们纳入标准的研究。两名评审员独立筛选文章。分歧由其他评审员解决。随后,使用标准化表格进行数据提取,并使用乔安娜·布里格斯研究所工具对研究进行质量评估。使用R软件进行荟萃分析。
经过各个筛选阶段,最终定量综合分析纳入了25项研究。孕妇心脏病的合并患病率为1.46%(95%CI 0.99 - 2.01)。在患有心脏病的患者中,70.25%(95%CI 64.87 - 75.38)患有风湿性心脏病,18.10%(95%CI 14.39 - 22.12)患有先天性心脏病。患有心脏病的孕妇早产和分娩的合并患病率为17.63%(95%CI 12.18 - 23.80)。同样,每1000名患有心脏病的孕妇的孕产妇和胎儿死亡率分别为26.14(95%CI 12.47 - 43.55)和50.48(95%CI 29.59 - 75.83)。
由于妊娠本身是一种长期的生理应激状态,心脏病会进一步增加母亲和胎儿的风险。鉴于患病率如此之高,必须努力在产前检测并密切监测病情,并应根据患者的临床情况做出决策。